ClearPoint Neuro, Inc.

NasdaqCM:CLPT 주식 보고서

시가총액: US$147.8m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

ClearPoint Neuro 미래 성장

Future 기준 확인 2/6

ClearPoint Neuro은 연간 수입과 매출이 각각 11.5%와 27.8% 증가할 것으로 예상되고 EPS는 연간 15.2%만큼 증가할 것으로 예상됩니다.

주요 정보

11.5%

수익 성장률

15.2%

EPS 성장률

Medical Equipment 수익 성장16.7%
매출 성장률27.8%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트20 Jun 2024

최근 미래 성장 업데이트

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 09
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Mar 15
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Recent updates

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 09
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

ClearPoint Neuro: Macro-Induced Multiple Compression

Apr 25

Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?

Apr 19
Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?

Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Mar 15
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?

Jan 04
Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?

Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Dec 06
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?

Nov 06
Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

Aug 18
Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump

Apr 17
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump

Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Jan 03
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

ClearPoint Neuro: Continuous Great Execution

Sep 19

ClearPoint Neuro: Picks & Shovels Galore

Aug 19

ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

Aug 18
ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

ClearPoint Neuro:  A 'Picks And Shovels' Biotech Company

Jul 25

ClearPoint Neuro: Continuous Execution Despite Covid Headwind

May 20

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

Apr 25
Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides

Mar 18

ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

Jan 19
ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

ClearPoint Neuro: Underlying Growth Potential Concealed By COVID

Jan 14

ClearPoint Neuro: Becoming The Neurosurgical Platform Of Choice

Oct 01

ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company

Aug 06

Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?

Jul 19
Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?

Clearpoint Neuro (CLPT) Investor Presentation - Slideshow

May 28

Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation

May 27
Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation

US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results

May 13
US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results

수익 및 매출 성장 예측

NasdaqCM:CLPT - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202658-15N/AN/A1
12/31/202542-17-3-33
12/31/202431-17-10-103
3/31/202426-21-13-12N/A
12/31/202324-22-15-14N/A
9/30/202322-22-17-16N/A
6/30/202322-21-19-18N/A
3/31/202321-18-19-18N/A
12/31/202221-16-17-16N/A
9/30/202220-16-18-17N/A
6/30/202219-16-17-16N/A
3/31/202217-16-15-15N/A
12/31/202116-14-13-13N/A
9/30/202116-12-12-12N/A
6/30/202115-9-10-10N/A
3/31/202114-7-8-8N/A
12/31/202013-7-8-8N/A
9/30/202012-7-6-6N/A
6/30/202012-6-6-5N/A
3/31/202012-6-5-5N/A
12/31/201911-6-3-3N/A
9/30/201910-5-3-3N/A
6/30/20199-5-3-3N/A
3/31/20198-6-3-3N/A
12/31/20187-6-5-5N/A
9/30/20187-7-6-6N/A
6/30/20187-7-7-6N/A
3/31/20187-7-7-7N/A
12/31/20177-7N/A-6N/A
9/30/20177-7N/A-5N/A
6/30/20177-8N/A-5N/A
3/31/20176-8N/A-6N/A
12/31/20166-8N/A-6N/A
9/30/20166-8N/A-6N/A
6/30/20165-5N/A-6N/A
3/31/20165-7N/A-7N/A
12/31/20155-8N/A-9N/A
9/30/20154-9N/A-9N/A
6/30/20153-13N/A-10N/A
3/31/20154-11N/A-9N/A
12/31/20144-5N/A-7N/A
9/30/20144-4N/A-7N/A
6/30/20144-4N/A-6N/A
3/31/20143-4N/A-7N/A
12/31/20134-7N/A-8N/A
9/30/20135-4N/A-8N/A

애널리스트 미래 성장 예측

수입 대 저축률: CLPT 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: CLPT 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: CLPT 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: CLPT 의 수익(연간 27.8% ) US 시장( 8.7% 보다 빠르게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: CLPT 의 수익(연간 27.8% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: CLPT 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견